Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare (NHC) Gross Profit (2016 - 2025)

Historic Gross Profit for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $286.1 million.

  • National Healthcare's Gross Profit rose 1100.86% to $286.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 2219.98%. This contributed to the annual value of $986.0 million for FY2024, which is 1554.22% up from last year.
  • Latest data reveals that National Healthcare reported Gross Profit of $286.1 million as of Q3 2025, which was up 1100.86% from $283.0 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Gross Profit registered a high of $286.1 million during Q3 2025, and its lowest value of $184.8 million during Q1 2021.
  • Its 5-year average for Gross Profit is $226.0 million, with a median of $216.0 million in 2023.
  • In the last 5 years, National Healthcare's Gross Profit plummeted by 1241.83% in 2022 and then skyrocketed by 2798.35% in 2025.
  • Over the past 5 years, National Healthcare's Gross Profit (Quarter) stood at $220.9 million in 2021, then decreased by 12.42% to $193.5 million in 2022, then increased by 18.86% to $229.9 million in 2023, then rose by 24.4% to $286.1 million in 2024, then grew by 0.0% to $286.1 million in 2025.
  • Its Gross Profit stands at $286.1 million for Q3 2025, versus $283.0 million for Q2 2025 and $281.2 million for Q1 2025.